GlassScriptPhysician profile
Abigail Allen
NPI 1265986269
$952.76
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $293 · 2023: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $221.78 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Lucid Diagnostics INC. | $125.16 | 2022 | |
| Esperion Therapeutics, INC. | $121.84 | 2021 | |
| Abbvie INC. | $105.27 | 2022-2023 | |
| Stryker Corporation | $68.29 | 2021 | |
| Pfizer INC. | $56.09 | 2022-2023 | |
| Lilly USA, LLC | $55.06 | 2022-2023 | Mounjaro, Trulicity |
| Dexcom, INC. | $44.00 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.87 | 2021-2023 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $20.31 | 2023 | |
| Ibsa Pharma INC. | $19.57 | 2022 | |
| Halozyme INC | $19.38 | 2023 | |
| Exact Sciences Corporation | $15.54 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.39 | 2022 | |
| Kerecis Limited | $14.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.